1 BTC
=
- USD
Veeva Systems Inc.
As of May 30, 2026 at 12:32 UTC
Chart
About Veeva Systems Inc.
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
Market Statistics
Trading Metrics
How to Buy VEEV
Create Your Account
Sign up, deposit BTC, and transfer it to your Unified Trading Account. It only takes a moment.
Start Your Trade
From Terminal, click Trade Now on the asset you want to buy. You'll be purchasing its tokenized asset.
Buy VEEV
Enter the amount and confirm your purchase. That's it! You'll see the impact of the trade in your Unified Trading Account.
New to Tokenized Assets? Learn more in our Help Center.
Latest News
5 articlesAccumulus Technologies launched Direct Connect for Veeva RIM, enabling real-time integration between regulatory information management systems and health authorities. The integration allows life sciences companies to manage regulatory interactions seamlessly within Veeva RIM while using Accumulus as a central global interface to regulators, reducing manual work and streamlining submission processes.
Accumulus Technologies has launched Accumulus Direct Connect for Veeva RIM, enabling real-time integration between regulatory information management systems and health authorities. The integration allows life sciences companies to streamline regulatory submissions and interactions within their existing Veeva RIM environment while using Accumulus as a single global connection point with regulators. Early adopter Amgen reports significant operational improvements including time savings and enhanced visibility.
The article recommends two growth stocks for long-term investors: Nvidia and Veeva Systems. Nvidia continues to lead the AI chip market with strong financial results and upcoming product releases expected to drive $1 trillion in orders through 2027. Veeva Systems, despite competitive pressures, maintains dominance in life sciences cloud solutions with high switching costs and strong financial growth, positioning both stocks as attractive investments for patient investors with a 5+ year horizon.
U.S. equities reached all-time highs on Friday as Apple's blowout Q2 earnings powered a broad technology rally. The S&P 500 advanced 0.7% to 7,262, while the Nasdaq 100 rose 1.1% to 27,743. Apple surged 5.1% on strong revenue and guidance, while software stocks like Atlassian, Twilio, and Reddit soared on earnings beats. Energy stocks declined as crude oil fell over 3%. Some mega-cap earnings disappointed, including Amgen and Roblox, which posted significant declines.
The clinical trial management system (CTMS) market is experiencing significant growth, expanding from $2.25 billion in 2025 to $2.54 billion in 2026 at a 13.1% CAGR, with projections reaching $4.2 billion by 2030. Growth is driven by increasing global clinical trials, adoption of cloud-based platforms, AI-powered analytics, and decentralized trial models. Key players are making strategic moves including platform launches and acquisitions to enhance technological capabilities.
